Related by context. All words. (Click for frequent words.) 63 Anticancer Drug 62 Lung Cancer Trial 62 Gastric Cancer 61 Prospective Randomized 61 Systemic Delivery 61 Therapeutic Antibody 61 Randomized Study 61 Pharmaceuticals Initiates 61 Prolongs Survival 60 RE MODEL 60 Breast Ultrasound 60 Cardiotoxicity 60 Diagnostic Tools 60 Therapy Improves 60 Phase 1b Clinical Trial 60 Biomarker Study 60 Randomised Controlled Trial 60 Chronic Lymphocytic Leukemia 60 Adjuvant Breast Cancer 59 Study Evaluating 59 Prospective Multicenter 59 Phase 2b Study 59 Adjuvant Chemotherapy 59 Neoadjuvant Chemotherapy 59 Non Invasive Treatment 59 Advanced Renal Cell 59 Phase III Clinical Trial 59 Lung Cancer Drug 59 Preclinical Models 59 Successfully Completes Phase 59 STENT 59 Eluting 59 Investigator Initiated 59 Randomized Evaluation 59 Clinical Trial Enrollment 59 Adjuvant Treatment 59 Pivotal Trial 59 Sirolimus Eluting Stent 59 Valve Replacement 58 Shows Promise Against 58 Confirmatory Phase 58 Phase Ib II 58 Protein Biomarker 58 Aortic Dissection 58 Cancer Stem Cells 58 Randomized Clinical Trials 58 Novel Inhibitor 58 Fallopian Tube 58 Protein Microarray 58 HDAC Inhibitor 58 Antithrombotic 58 Renal Failure 58 Antiviral Activity 58 Lupus Drug 58 Kinase Inhibitor 58 Teva Provides Update 58 Illumina Infinium 58 Percutaneous Tibial Nerve Stimulation 58 Improves Outcomes 58 multicentre randomized 58 Inflammatory Disease 58 Ovarian Cancer Treatment 58 Tyrosine Kinase Inhibitor 58 Phase III Trial 58 Therapy Shows Promise 58 Immunomodulatory 58 Therapeutic Vaccine 58 Shows Promising 57 Gene Expression Analysis 57 Enters Beta 57 Helps Predict 57 Hepatocellular Carcinoma 57 Combination Treatment 57 Bipolar Depression 57 Angiogenic 57 Lung Cancer Survival 57 Carotid Endarterectomy 57 Randomized Trials 57 Interferon Alfa 57 Brain Tumor Therapy 57 Clinical Trial Data 57 Virtual Histology 57 Renal Cancer 57 Dilated Cardiomyopathy 57 Randomised 57 Ebola Vaccine 57 Retrovirus 57 Autoimmune Disease 57 Bone Marrow Stem Cell 57 Breast Cancer Recurrence 57 Oral Presentations 57 Phase Ib Clinical Trial 57 Pivotal Study 57 Anti Tumor 57 Phase III Clinical Trials 57 First Patient Enrolled 57 Male Contraceptive 57 Biologic Therapy 57 Improves Survival 57 Stem Cell Treatment 57 Potent Inhibitor 57 Lung Tumors 57 Hormone Refractory Prostate Cancer 57 Genes Involved 57 Kinase Inhibitors 57 Anti Platelet 57 Phenotyping 57 Intervention Trial 57 Confirms Efficacy 57 HCV Protease Inhibitor 56 Could Predict 56 Imaging Techniques 56 Protease Inhibitors 56 Breast Cancer Cells 56 Disease Progression 56 Combination REOLYSIN R 56 Prostate Cancer Vaccine 56 Protein Synthesis 56 Advanced Melanoma 56 Prevent Stroke 56 Treating Chronic 56 HER2 Positive Breast Cancer 56 Randomized Double Blind 56 Systemic Sclerosis 56 Iron Overload 56 Pivotal Trials 56 Hepatitis C Treatment 56 Demonstrates Statistically Significant 56 Innate Immune 56 Newly Identified 56 Diabetic Foot Ulcer 56 Molecular Diagnostic 56 Anticancer Agent 56 Largest Database 56 FDA Approvals 56 Polymorphism 56 Delcath Phase III 56 Patient Enrolment 56 Preclinical Study 56 Phase III multicenter 56 Transcatheter Valve 56 Clinical Evaluation 56 Genetic Predisposition 56 Vaccine Trials 56 Egg Freezing 56 Initiated Phase 56 Pharmacokinetic Study 56 Drug Shows Promise 56 Immunotherapeutic 56 ATAC Arimidex Tamoxifen Alone 56 Dose Escalation 56 Brain Metastases 56 Risk Stratification 56 Anticancer Activity 56 Multiple Ascending Dose 56 Breast Brachytherapy 56 First Patient Dosed 56 CALGB 56 Anti CD# Antibody 56 Stent Restenosis 56 Demonstrates Sustained 56 Sipuleucel T 56 Initiate Phase III 56 Interferon Gamma 56 Renal Cell Carcinoma 56 ABRF 56 PET Scanner 56 Diagnostic Tests 56 Progenitor Cell 56 Myocardial Infarction Study 56 Genes Linked 56 Investigational Drug 56 Clinical Trial Results 56 Genetic Disorder 56 Immunosuppression 56 Pertuzumab 56 Acute Heart Failure 56 Synthetic Peptide 56 Observational Study 56 Study Shows Benefits 56 Protease Inhibitor 56 Ovarian Cancer Patients 56 Combo Therapy 56 Acute Ischemic Stroke 56 Artificial Cornea 56 Protein Expression 56 Estrogen Receptor 56 EGIR 56 Angiographic 55 Predict Breast Cancer 55 Tablet Formulation 55 Left Ventricular 55 Mitochondrial Dysfunction 55 Initiates Clinical Trial 55 Novel Therapeutic 55 Oncolytic Reovirus 55 BR.# 55 Malignant Melanoma 55 Phase 2b Clinical Trial 55 Patient Outcomes 55 Pooled Analysis 55 Anticancer Drugs 55 Laryngeal Cancer 55 Oral Fingolimod 55 Phase IIIb 55 Severe Sepsis 55 Fungal Infections 55 TMC# C# 55 Warfarin Sensitivity 55 Acute Myocardial Infarction 55 FDA Okays 55 Virus Infection 55 IND Application 55 Human Neural Stem 55 Study Demonstrates 55 ToGA 55 Novel Antibiotic 55 Initiates Phase 2b 55 Chemotherapy Improves 55 Glatiramer Acetate 55 Randomized Phase III 55 TB Vaccine 55 Whole Genome Sequencing 55 Randomized Controlled 55 NCIC CTG 55 Cinacalcet 55 CABANA 55 CURRENT OASIS 7 55 Clinical Outcome 55 Podium Presentation 55 Breast Cancer Diagnosis 55 Treatment Approaches 55 Therapeutic Antibodies 55 Glioma 55 Vertebral Compression Fracture 55 Multicenter 55 NABTT 55 Subgroup Analysis 55 AnaSpec Introduces 55 WARFARIN 55 Prognostic Value 55 Multicenter Randomized 55 Targeted Therapies 55 Recurrent Prostate Cancer 55 Initiates Phase II 55 Schizophrenia Treatment 55 Progenitor Cells 55 Cancer Vaccines 55 Proves Successful 55 Completes Enrollment 55 Treated Patients 55 Antiepileptic Drug 55 multicenter multinational 55 Binding Site 55 Patient Enrollment 55 Analytical Tool 55 WHO TDR 55 Psoriasis Drug 55 Prostate Biopsy 55 Parenteral Nutrition 55 Autoimmune Diseases 55 Drug Candidate 55 Hernia Repair 55 Breast Ovarian Cancer 55 Patients Enrolled 55 Microfluidic Device 55 Antiangiogenic 55 Rotavirus Vaccine 55 Coronary Revascularization 55 Diastolic Heart Failure 55 Mutagenesis 55 Protein Structure 55 Bosutinib 55 Files IND 55 Protein Interaction 55 Glycosylation 55 Demonstrates Efficacy 55 Phase 2a Clinical Trial 55 Demonstrates Potential 55 Postdoctoral Position 55 Autologous Stem Cell Transplantation 55 Aptamer 55 Systemic Lupus Erythematosus SLE 55 Anti Tumor Activity 55 Molecular Diagnostic Test 55 Differential Diagnosis 55 Mesenchymal Stem Cells 55 Thrombotic 55 Immune Cell 55 Avian Flu Vaccine 55 Myoblast 55 Drug Eluting 55 Contrast Agent 55 Unresectable 55 Human Leukocyte Antigen 55 Novel Mechanism 55 Therapeutic Arthritis 55 multicenter randomized controlled 55 biliary tract cancer 55 Investigational Agent 55 Pharmacokinetics PK 55 Cholesterol Lowering Drug 54 Single Molecule 54 Contrast Agents 54 peptide conjugated 54 Hedgehog Pathway Inhibitor 54 EntreMed Presents 54 IIa Clinical Trial 54 Smooth Muscle 54 Phase III Psoriasis 54 Personalised Medicine 54 Daclizumab 54 CRLX# 54 Recurrent Breast Cancer 54 NSABP B 54 Genetic Markers 54 Virus Linked 54 PRESEPT 54 Replacement Therapy 54 Placebo Controlled Trial 54 Phase IIb Trial 54 Transcription Factor 54 Drug Fails 54 Novel Oral 54 Mouse Model 54 Gene Mutation 54 Improved Survival 54 Slows Progression 54 Interferon Alpha 54 Restless Legs 54 Bayer HealthCare Onyx Pharmaceuticals 54 Valvular Heart Disease 54 Test Detects 54 Antiviral Therapy 54 Randomized Clinical Trial 54 Targeted Therapy 54 Gastrointestinal Disorders 54 Proven Effective 54 Cellular Immunotherapy 54 Less Invasive 54 multicenter randomized clinical 54 Clinical Validation 54 Catheter Ablation 54 Novel Approach 54 Advanced Prostate Cancer 54 BCIRG 54 Pivotal Phase III 54 PRoFESS 54 Lung Injury 54 Preclinical Data 54 Metastatic Breast Cancer 54 OvaRex MAb 54 Circulating Tumor Cells 54 Multicenter Trial 54 Artery Disease 54 Phase III Trials 54 Cardiomyocytes 54 Chemotherapy Regimen 54 See CLINICAL PHARMACOLOGY 54 Anti Angiogenic 54 Antiarrhythmic 54 Biorepository 54 Phase Ib clinical 54 Hepatic Encephalopathy 54 Breast Tumor 54 Peripheral Blood 54 ONTARGET 54 Activated Checkpoint Therapy 54 Patients Treated With 54 Testosterone Patch 54 Initiates Phase III 54 Castration Resistant Prostate Cancer 54 Cell Lymphoma 54 Gout Drug 54 Coronary Intervention 54 Inflammatory Markers 54 Male Infertility 54 Prognostic Significance 54 Targeted Therapeutics 54 Ceflatonin R 54 MR Angiography 54 GeneSightRx 54 InForm ™ 54 Val HeFT 54 Commences Phase 54 Randomized Phase II 54 Partial Nephrectomy 54 Biomarker Panel 54 Extended Dosing 54 Leukemias 54 Cell Adhesion 54 Metastatic Renal Cell Carcinoma 54 Aureon 54 Epitopes 54 HER2 Positive 54 Chemoradiation 54 Breast Cancer Stem Cells 54 Pivotal Phase II 54 Chronic Heart Failure 54 HORIZONS AMI 54 Multicenter Randomized Double 54 Oral Cavity 54 Prognostic Factors 54 Antibiotic Resistant Bacteria 54 Microbial Detection 54 Bladder Cancer 54 Carotid 54 Mesothelioma Treatment 54 Kidney Function 54 Liver Tumors 54 Hsp# Inhibitor 54 Virtual Microscopy 54 Optical Coherence Tomography 54 RE LY ® 54 Reduce Cardiovascular 54 Brain Scans 54 RE LY 54 Stem Cell Differentiation 54 Vaccine Shows Promise 54 Anticancer Compound 54 Completes Patient Enrollment 54 multicenter prospective 54 multicenter randomized placebo controlled 54 Proves Effective 54 Cardiac Function 54 Carotid Stenting 54 IIa clinical 54 Deforolimus 54 Diamyd Medical Diamyd 53 ISTODAX ® 53 Late Breaker 53 INTERACT 53 Small Vessel 53 Roche cobas 53 Initiates Clinical 53 Vivo Imaging 53 Adjuvant Therapy 53 Malaria Vaccine 53 Transdermal Delivery 53 BIOLASE Announces 53 PET CT Scanner 53 Neuroprotection 53 Yates Retrial 53 Antigen Specific 53 Hematopoietic Stem Cells 53 Hematological Cancers 53 Fibromyalgia Syndrome 53 Aggressive Reduction 53 Tuberculosis Vaccine 53 Chronic Myeloid Leukemia 53 CLARITY TIMI 53 Breast Cancer Metastasis 53 Genetic Susceptibility 53 Pharmacogenomic 53 Syllego system 53 Treating Depression 53 Spine Patient Outcomes 53 Stem Cell Transplants 53 Rheumatoid Arthritis Patients 53 Chronic Lymphocytic Leukemia CLL 53 Gastrointestinal Stromal Tumors 53 Novel Approaches 53 Meets Primary Endpoint 53 Study Shows Significant 53 AurSCOPE 53 Early Relapsing Multiple 53 Pulmonary Artery 53 Node Positive 53 CHMP Opinion 53 Lipid Lowering 53 ENESTnd 53 Gram Negative 53 Could Save Lives 53 Key Milestones 53 Antibody Drug Conjugate 53 Peer Reviewed Publication 53 Predict Risk 53 Structure Function 53 Stent Thrombosis 53 PHASE III 53 Genes Predict 53 Vertebral Fracture 53 Inhibits Growth 53 Lung Cancer Screening 53 Multicenter Phase 53 Phase IIA 53 Fragment Library 53 Motility 53 Proteasome 53 Reduced Risk 53 Oral Insulin 53 Investigational Treatment 53 Refractory Angina 53 Interferon Beta 53 Neoplasms 53 Molecular Mechanisms 53 Stent Implantation 53 blinded randomized placebo controlled 53 Dose Ranging 53 Demonstrates Significant 53 Colorectal Cancer Patients 53 Genentech Provides Update 53 Ischemic Stroke 53 Shows Efficacy 53 Enzyme Linked 53 Patent Infringement Litigation 53 Single Dose 53 Conjugate 53 atypical Hemolytic Uremic Syndrome 53 JAK Inhibitor 53 Monoclonal Antibody 53 Prolongs Life 53 Myelodysplastic Syndromes 53 Aethlon Medical Announces 53 Stereotactic Radiotherapy 53 Initiate Phase 53 Skin Lesions 53 Tumor Microenvironment 53 REALITY Trial 53 Kidney Transplant Patients 53 Demonstrates Positive 53 Epithelium 53 Trial Evaluating 53 Nicotine Vaccine 53 Platelet Function 53 Oligonucleotide 53 Skin Grafts 53 Infarct 53 Enhanced Version 53 Phase IIb Clinical Trial 53 Artificial Pancreas 53 Heart Failure Therapy 53 YONDELIS R 53 Systemic Therapy 53 Pivotal Phase 53 ara C 53 Clinical Efficacy 53 Erythropoietic 53 Non Inferiority 53 Pneumonia Vaccine 53 Migraine Drug 53 Endovascular Repair 53 Combination Therapy 53 Randomized Controlled Trials 53 RhuDex 53 Diagnostic Criteria 53 Fully Functional 53 Hematological 53 Remission Maintenance 53 TECHNOLOGIST 53 Transplant Rejection 53 Tyrosine Kinase Inhibitors 53 Nerve Cell 53 Vaccine Trial 53 Hormone Receptor Positive 53 Oral Mucositis 53 Renal Cell Cancer 53 ZACTIMA 53 CAMMS# 53 prospective multicenter 53 Treatment Algorithm 53 Peripheral Arterial 53 Is Well Tolerated 53 Stakeholder Opinions 53 Hematological Malignancies 53 Cytotoxicity 53 Antitumor 53 fosbretabulin 53 Cellular Therapies 53 Long Lesion 53 Phase IIa Clinical Trial 53 Phase 2b Trial 53 Mimetics 53 AASLD Meeting 53 GENOME 53 essential thrombocythemia ET 53 Noninvasive Prenatal 53 Heart Failure Treatment 53 Protein Involved 53 Interpersonal Psychotherapy 53 Pulmonary Arterial Hypertension 53 Anti Angiogenesis 53 Double Blind Placebo 53 Oligonucleotides 53 Novel Therapies 53 Subset 53 PROMETHEUS 53 Ridaforolimus 53 Respiratory Distress 53 Self Assembling 53 Vasculitis 53 Dose Response 53 Monoclonal antibody 53 Script Insertion Vulnerability 53 TAXUS ATLAS 53 Balloon Angioplasty 53 Lifestyle Intervention 53 registrational Phase 53 Novel Biomarkers 53 Metastatic Pancreatic Cancer 53 Pegylated Liposomal Doxorubicin 53 Magnetic Nanoparticles 53 Aneurysm Repair 53 Severe Asthma 53 Trastuzumab DM1 53 Theranostics 53 Intravascular 53 Inflammatory Arthritis 53 Human Antibody 53 Cardiac Rhythm 53 Bacterial Cell 53 Liver Cancer 53 Cell Transplant 53 Molecular Mechanism 53 Inhaled Corticosteroids 53 Helps Identify 53 Neural Stem Cells 53 Efficacy Trial 53 Acute Leukemia 53 Therapeutic Effects 53 II Clinical Trial 52 CellSearch TM 52 Brentuximab Vedotin SGN 52 Prostate Cancer Patients 52 Low Incidence 52 Epithelial Cell 52 Significantly Improved 52 Sapacitabine 52 Recurrent Glioblastoma 52 Cognitive Problems 52 Metabolic Disorder 52 Treatment Naive 52 Bioequivalence 52 Predict Response 52 Regimens 52 Cannabinoid 52 Helps Diagnose 52 FDA Approves Drug 52 Cancer Therapies 52 Cardiac Resynchronization Therapy 52 Phenotypes 52 Effectively Treats 52 ASSERT 52 Minimally Invasive Treatment 52 Immunostimulatory 52 PROactive Study 52 RNA Interference 52 Evaluation Program CTEP 52 Liver Fibrosis 52 Highly Potent 52 Clostridium difficile Infection 52 Molecular Genetic 52 v#.# Released [002] 52 Immunomedics Announces 52 relapsing multiple sclerosis 52 Node Negative 52 Metastatic Colorectal Cancer 52 Lymphocytic 52 Bone Marrow Stem Cells 52 assessing T DM1 52 Unstable Angina 52 Blood Cancers 52 Blood Pressure Drug 52 Atrial Fibrillation Treatment 52 Soy Isoflavones 52 Cardiovasc 52 Highly Accurate 52 Osteoporosis Treatment 52 Antipsychotic Drug 52 SARS Virus 52 Improve Outcomes 52 Slow Progression 52 Watchful Waiting 52 Metastatic Melanoma 52 Seasonal Influenza Vaccine 52 TenFold Announces 52 Influenza Vaccine Production 52 evaluating mipomersen 52 Efficiently Manage 52 Therapeutic Targets 52 Combination Clinical Trial 52 Survival Benefit 52 Disease Modifying 52 Surgical Technique 52 Fully Automated 52 Data Extraction 52 Hormone Receptor 52 Provides Insights 52 Resynchronization 52 Zero Footprint 52 Significantly Improves 52 Lowers Risk 52 Uterine Cancer 52 Ultrasound Imaging 52 Predict Prostate Cancer 52 Present Preclinical Data 52 Immunosuppressant 52 multicentre randomized controlled 52 Myelofibrosis 52 Detecting Breast Cancer 52 Aurora Kinase 52 Genes Identified 52 ENDEAVOR IV 52 Improves Quality 52 Study Showed 52 Protein Linked 52 Adult Stem Cell Therapy 52 Announce Collaboration Agreement 52 Colour Coded 52 Secretion 52 Tumor Targeting 52 + Perifosine Evaluation 52 Carotid Revascularization Endarterectomy vs. 52 Gene Variants 52 Stable Angina 52 Follicular Lymphoma 52 Lysis 52 First Episode Psychosis 52 Ischaemic 52 Placebo Controlled Study 52 Lung Cancer Treatment 52 Therapeutic Efficacy 52 Saves Money 52 EORTC 52 Relapsing Multiple Sclerosis 52 Long Term Efficacy 52 Proc Am Soc 52 Phase III psoriasis 52 Relieve Pain 52 Antitumor Activity 52 Prostate Cancer Treatment 52 Brain Wiring 52 Omacetaxine 52 Statistically Significant 52 Nano Sized 52 Phase 2a Trial 52 Being Studied 52 Early Lung Cancer 52 Nonalcoholic Fatty Liver Disease 52 Quadrivalent 52 syngo R 52 Files Investigational 52 Double Blind Randomized 52 Erectile Dysfunction Drug 52 Liver Metastases 52 Biotracker 52 Image Guided 52 Treatment Reduces 52 Study Reinforces 52 Biomarker Discovery 52 Patient Oriented 52 Muscle Wasting 52 Drug Prevents 52 Multicenter Study 52 Ellex 2RT 52 Asthma COPD 52 Newly Diagnosed 52 Cervical Spine 52 Shown Effective 52 Adverse Event 52 Lung Cancer Vaccine 52 Tumor Angiogenesis 52 Novel Vaccine 52 Skin Cells 52 Oral Anticoagulant 52 Topical Treatment 52 Renal Insufficiency 52 Diasome 52 Aplidin 52 HyACT 52 SWOG 52 Protease 52 Releases Podcast On 52 Pre RELAX AHF 52 Oncomine 52 Kidney Transplants 52 Susceptibility Gene 52 ASGCT 52 Atypical Hemolytic Uremic Syndrome 52 Omnitarg 52 Cutaneous T 52 Suicidality 52 Randomized Phase 52 Islet Transplantation 52 Cell Signaling 52 Prostate Cancer Survival 52 Study Pinpoints 52 Idiopathic Pulmonary Fibrosis 52 IMPACT IMmunotherapy 52 Phospho 52 Prostate Cancer Cells 52 Genetic Disorders 52 Agfa HealthCare IMPAX 52 Diabetic Nephropathy 52 Flagship Product 52 Anti VEGF 52 Tumor Suppressor 52 XPEL Announces 52 KEY FACTS 52 Active Ulcerative Colitis 52 Glucosamine Chondroitin Arthritis 52 Endovascular System 52 Coronary Artery Calcium 52 Breast Cancer Treatment 52 Relapsed Refractory 52 Appears Safe 51 Vascular Stent 51 CT Angiography 51 Hereditary Breast Cancer 51 Scientists Unravel 51 Prefilled Syringes 51 Estrogen Therapy 51 Individualized Treatment 51 Breast Density 51 Genetic Defect 51 Clinical Trial Evaluating 51 Bioresearch 51 Triapine 51 Pathwork 51 Neural Regeneration 51 Chronic Myelogenous Leukemia 51 Lung Tumor 51 Protein Kinase 51 Edge STudy 51 Dose Escalation Study 51 Localized Prostate Cancer 51 Device Helps 51 Lupus Nephritis 51 Help Diagnose 51 Clinical Study Shows 51 Renal Function 51 Antidepressant Treatment 51 Low Dose 51 Asymptomatic Carotid 51 Treatment Regimen 51 Plasma Protein 51 Sequence Analysis 51 Co Receptor Tropism 51 Osteoporosis Drug 51 Testing Methodology 51 RNAi Therapeutic 51 Phase 1a clinical 51 Glaucoma Treatment 51 CT Scanning 51 Induction Therapy 51 Protein Interactions 51 Head Lice Treatment 51 Renal Anemia 51 Controlled Trial 51 Biobanking 51 Password Protected 51 Avila Therapeutics 51 Commercially Available 51 Artificial Liver 51 Multicentre 51 Cholesterol Drug 51 Atopic Dermatitis 51 Detect Cancer 51 randomized Phase III 51 Adsorbent 51 Viral Infections 51 Crit Rev 51 Skeletal Muscle 51 Cervical Cancer Detection 51 multikinase inhibitor 51 Sensor Fusion 51 Improve Survival 51 Liver Transplant Patients 51 Microplate Readers 51 Therapeutic Approaches 51 Prostatic 51 Romidepsin 51 Anticoagulation 51 Arthritis Drug 51 Glucose Monitoring System 51 Emerging Therapies 51 metastatic neuroendocrine tumors 51 Viralytics 51 Anticancer Agents 51 Anti Inflammatory Drugs 51 CupPrint 51 eDiaries 51 MMR Vaccine 51 Multiple Myeloma MM 51 Mimetic 51 Genetic Tests 51 Microbicide 51 Versus Placebo 51 Periodontal Disease 51 THEW 51 Novel Antibody 51 Efficacy Endpoints 51 AACR Meeting 51 ARRY # 51 TM Drug Eluting 51 Clinical Remission 51 Breast Tumors 51 BellBrook Labs 51 Treatment Experienced 51 Dendritic Cells 51 Signaling Pathways 51 Placebo Controlled 51 Product Rollout 51 Multidrug Resistant 51 Novel Protein 51 Tolerability Study 51 ASTEROID 51 Chronic Inflammation 51 Aflibercept 51 Demonstrated Significant 51 Reduce Mortality 51 Patient Treated 51 Script Insertion 51 Chelation Therapy 51 Imaging Technique 51 DIAGNOSTIC 51 AND SERVE 51 Immunogenic 51 SimSuite 51 Reduces Pain 51 Comput 51 Treatment Shows Promise 51 Diabetic Ulcers 51 Therapeutic Potential 51 Novel Compound 51 Allograft 51 Therapeutic Intervention 51 Particle Characterization 51 Herbal Remedy 51 OSLER 51 Immune Mediated 51 Pivotal Clinical Trial 51 Plaque Psoriasis 51 Protein Structures 51 Retroviral 51 Randomized Double blind 51 Renin Inhibitor 51 NT proBNP Test 51 Quotient Bioresearch 51 Prenatal Diagnosis 51 Drug Resistant Tuberculosis 51 Genisphere 51 Chemoprevention 51 Hospitalized Patients 51 Calorie Diet 51 Solid Tumors 51 Multiple Myeloma Patients 51 Autoimmune Disorders 51 Intravenous Formulation 51 Genetic Variation 51 Randomized controlled 51 Gluten Intolerance 51 Study Casts Doubt 51 Inhaled Insulin 51 multicenter Phase II 51 Reflux Disease 51 ICANN Approves 51 Patient Populations 51 Muscle Cells 51 Electrophysiology Mapping 51 Guidelines Recommend 51 Patients Treated 51 Fingerprint Biometric 51 multicenter placebo controlled 51 Select Biosciences 51 IND Filing 51 VERTEX 51 Cavitation Technologies 51 Venous Leg Ulcers 51 Small Molecule 51 PREVU * 51 Begin Clinical Trials 51 Genetic Mutation 51 Heart Failure Patients 51 Long Term Outcomes 51 Transmembrane 51 Invasive Fungal Infections 51 Arterial Disease 51 Aortic Valve 51 Oral Fluid 51 Hypertrophy 51 Radioimmunotherapy 51 metastatic malignant 51 Biosensor System 51 receptor tyrosine kinase inhibitor 51 ALSYMPCA 51 docetaxel cisplatin 51 Achieve Optimal 51 Small Molecules 51 Hormonal Therapy 51 Lowering Blood Pressure 51 Menstrual Pain 51 Diabetic Neuropathy 51 Transdermal Patch 51 TR FRET 51 Blood Clotting 51 randomized multicenter 51 Microfluidic Devices 51 AntiOnline Spotlight